1. Holmes, K.V. (2003) SARS coronavirus: a new challenge for prevention and therapy. J. Clin. Invest.
111, 1605–1609.
2. Peiris, J. S., Guan, Y., and Yuen, K. Y. (2004) Severe acute respiratory syndrome. Nature Med.
10, S88–97.
3. Tsunetsugu-Yokota, Y., Ohnishi, K., and Takemori, T. (2006) Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine. Rev. Med. Virol.
16, 117–131.
4. Takasuka, N., Fujii, H., Takahashi, Y., Kasai, M., Morikawa, S., Itamura, S., Ishii, K., Sakaguchi, M., Ohnishi, K., Ohshima, M., Hashimoto, S., Odagiri, T., Tashiro, M., Yoshikura, H., Takemori, T., and Tsunetsugu-Yokota, Y. (2004) A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice. Int. Immunol.
16, 1423–1430.
5. Ohnishi, K., Sakaguchi, M., Kaji, T., Akagawa, K., Taniyama, T., Kasai, M., Tsunetsugu-Yokota, Y., Oshima, M., Yamamoto, K., Takasuka, N., Hashimoto, S., Ato, M., Fujii, H., Takahashi, Y., Morikawa, S., Ishii, K., Sata, T., Takagi, H., Itamura, S., Odagiri, T., Miyamura, T., Kurane, I., Tashiro, M., Kurata, T., Yoshikura, H., and Takemori, T. (2005) Immunological detection of severe acute respiratory syndrome coronavirus by monoclonal antibodies. Jpn. J. Infect. Dis.
58, 88–94.